CoChat

Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Increasing evidence suggests that environmental neurotoxicants or misfolded α-synuclein generated by such neurotoxicants are transported from the gastrointestinal tract to the central nervous system via the vagus nerve, triggering degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and causing Parkinson’s disease (PD). We tested the hypothesis that gastric co-administration of subthreshold doses of lectins and paraquat can recreate the pathology and behavioral manifestations of PD in rats. A solution containing paraquat + lectin was administered daily for 7 days via gastric gavage, followed by testing for Parkinsonian behavior and gastric dysmotility. At the end of the experiment, brainstem and midbrain tissues were analyzed for the presence of misfolded α-synuclein and neuronal loss in the SNpc and in the dorsal motor nucleus of the vagus (DMV). Misfolded α-synuclein was found in DMV and SNpc neurons. A significant decrease in tyrosine hydroxylase positive dopaminergic neurons was noted in the SNpc, conversely there was no apparent loss of cholinergic neurons of the DMV. Nigrovagally-evoked gastric motility was impaired in treated rats prior to the onset of parkinsonism, the motor deficits of which were improved by l-dopa treatment. Vagotomy prevented the development of parkinsonian symptoms and constrained the appearance of misfolded α-synuclein to myenteric neurons. These data demonstrate that co-administration of subthreshold doses of paraquat and lectin induces progressive, l-dopa-responsive parkinsonism that is preceded by gastric dysmotility. This novel preclinical model of environmentally triggered PD provides functional support for Braak’s staging hypothesis of idiopathic PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41531-018-0066-0

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Incubation with paraquat + lectin increases the rate of α-synuclein fibrillation. a Time course of α-synuclein fibrillation in the presence of α-synuclein alone (white, α-syn, n = 6), paraquat (light gray, P, n = 7), lectin (dark gray, L, n = 4) or a combination of paraquat + lectin (black, P + L, n = 6). b Graphic summary of fibrillation t1/2 for α-synuclein. *p < 0.05 vs. α-synuclein alone; #p < 0.05 vs. paraquat or lectin
Fig. 1 Incubation with paraquat + lectin increases the rate of α-synuclein fibrillation. a Time course of α-synuclein fibrillation in the presence of α-synuclein alone (white, α-syn, n = 6), paraquat (light gray, P, n = 7), lectin (dark gray, L, n = 4) or a combination of paraquat + lectin (black, P + L, n = 6). b Graphic summary of fibrillation t1/2 for α-synuclein. *p < 0.05 vs. α-synuclein alone; #p < 0.05 vs. paraquat or lectinCC BY · PubMed Central
Fig. 2 Paraquat + lectin treatment promotes α-synuclein misfolding in myenteric neurons of the GI tract. Representative micrographs showing 129Ser α-synuclein in the myenteric plexus isolated from the stomach a, d, g, j, the small intestine b, e, h, k, and the large intestine c, f, i, l from control animals (top row), animals sacrificed two (second row) or four (third row) weeks after the end of the gavage with paraquat + lectin, or animals that received subdiaphragmatic vagotomy prior to the paraquat + lectin treatment (bottom row). Calibration bars: 50 μm
Fig. 2 Paraquat + lectin treatment promotes α-synuclein misfolding in myenteric neurons of the GI tract. Representative micrographs showing 129Ser α-synuclein in the myenteric plexus isolated from the stomach a, d, g, j, the small intestine b, e, h, k, and the large intestine c, f, i, l from control animals (top row), animals sacrificed two (second row) or four (third row) weeks after the end of the gavage with paraquat + lectin, or animals that received subdiaphragmatic vagotomy prior to the paraquat + lectin treatment (bottom row). Calibration bars: 50 μmCC BY · PubMed Central
Fig. 3 Misfolded α-synuclein is present in the DMV, the A2 area, and the SNpc after treatment with paraquat and lectin. Representative micrographs showing the co-localization of ChAT- or TH-immunoreactivity and 129Ser α-synuclein-immunoreactivity. Representative micrographs showing the same rostro-caudal level of the DMV in control a, 2 d, and 4 g weeks after the last gavage with paraquat and lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment j. ChAT-immunoreactivity (brown, a, d, and j; blue in g) and 129Ser α -synuclein (blue in a, d, and j; brown in g); calibration bar: 75 µm. Representative micrographs showing the A2 area in control b, 2 e, and 4 h weeks after the last gavage with paraquat + lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment k. TH-IR (brown) and 129Ser α -synuclein (blue); calibration bar: 75 µm. Representative micrographs showing the same area of the SNpc in control c, 2 f, and 4 i weeks after the last gavage with paraquat + lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment l. TH-IR (brown) and 129Ser α -synuclein (blue); calibration bar: 50 µm. Insets are higher magnifications of their respective panels
Fig. 3 Misfolded α-synuclein is present in the DMV, the A2 area, and the SNpc after treatment with paraquat and lectin. Representative micrographs showing the co-localization of ChAT- or TH-immunoreactivity and 129Ser α-synuclein-immunoreactivity. Representative micrographs showing the same rostro-caudal level of the DMV in control a, 2 d, and 4 g weeks after the last gavage with paraquat and lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment j. ChAT-immunoreactivity (brown, a, d, and j; blue in g) and 129Ser α -synuclein (blue in a, d, and j; brown in g); calibration bar: 75 µm. Representative micrographs showing the A2 area in control b, 2 e, and 4 h weeks after the last gavage with paraquat + lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment k. TH-IR (brown) and 129Ser α -synuclein (blue); calibration bar: 75 µm. Representative micrographs showing the same area of the SNpc in control c, 2 f, and 4 i weeks after the last gavage with paraquat + lectin, or in animals that received subdiaphragmatic vagotomy prior to the treatment l. TH-IR (brown) and 129Ser α -synuclein (blue); calibration bar: 50 µm. Insets are higher magnifications of their respective panelsCC BY · PubMed Central
Fig. 4 Paraquat and lectin treatment impairs motor activity. Graphic summary showing the motor performance of rats examined with the vibrissae a and stepping b tests following treatment with paraquat + lectin. Note that the motor activity was significantly reduced two weeks after the end of treatment and persisted thereafter. l-dopa pretreatment induced a significant improvement of motor performance assessed with the vibrissae test (n = 12). Animals that received subdiaphragmatic vagotomy (n = 9) prior to the treatment did not show any motor impairment. *p < 0.05 vs. baseline
Fig. 4 Paraquat and lectin treatment impairs motor activity. Graphic summary showing the motor performance of rats examined with the vibrissae a and stepping b tests following treatment with paraquat + lectin. Note that the motor activity was significantly reduced two weeks after the end of treatment and persisted thereafter. l-dopa pretreatment induced a significant improvement of motor performance assessed with the vibrissae test (n = 12). Animals that received subdiaphragmatic vagotomy (n = 9) prior to the treatment did not show any motor impairment. *p < 0.05 vs. baselineCC BY · PubMed Central
Fig. 5 Treatment with paraquat + lectin induces loss of TH-positive neurons in the SNpc. Representative images of TH-positive neurons in SNpc of control a and treated animals b. Insets are higher magnifications of the boxed areas in the respective panels. Calibration bar: 100 µm. Graphic summary of TH-IR neuronal number in both the left c and right d SNpc of control (white) and P + L treated (black) rats. Note that a significant loss of neurons was detected in SNpc of animals 4 weeks after the last gavage of paraquat + lectin (n = 3 for controls and 4 for P + L 4 weeks, respectively; *p < 0.05 vs. control). d Graphic summary showing that the mean estimate number of TH-IR neurons is not significantly different from the mean estimate number of CV-positive neurons in the SNpc of P + L treated animals (n = 4)
Fig. 5 Treatment with paraquat + lectin induces loss of TH-positive neurons in the SNpc. Representative images of TH-positive neurons in SNpc of control a and treated animals b. Insets are higher magnifications of the boxed areas in the respective panels. Calibration bar: 100 µm. Graphic summary of TH-IR neuronal number in both the left c and right d SNpc of control (white) and P + L treated (black) rats. Note that a significant loss of neurons was detected in SNpc of animals 4 weeks after the last gavage of paraquat + lectin (n = 3 for controls and 4 for P + L 4 weeks, respectively; *p < 0.05 vs. control). d Graphic summary showing that the mean estimate number of TH-IR neurons is not significantly different from the mean estimate number of CV-positive neurons in the SNpc of P + L treated animals (n = 4)CC BY · PubMed Central
Fig. 6 Treatment with paraquat and lectin induces impairment of the nigro–vagal pathway. a Representative recordings from the gastric antrum showing that the increase of tone and motility following microinjection of NMDA in the left SNpc was reduced progressively at 2 and 4 weeks after the last gavage treatment. b Bottom panel: graphic summaries showing that 2 or 4 weeks after the paraquat and lectin treatment, microinjection of NMDA in the left SNpc increased gastric antrum tone (n = 9, 6, 10 for control, P + L 2 weeks and P + L 4 weeks, respectively) and motility (n = 7, 7, 9 for control, P + L 2 weeks and P + L 4 weeks, respectively) to a significantly lesser extent than in controls (*p < 0.05 vs. control). c Representative recordings from the gastric antrum showing that the increase of tone and motility following microinjection of TRH (1 pmole/60 nl) in the DMV was reduced progressively at 2 and 4 weeks after the last gavage treatment. d Graphic summaries showing that, 2 or 4 weeks after the paraquat and lectin treatment, microinjection of TRH (0.1–3 pmoles/60 nl) in the DMV increased gastric antrum tone and motility to a significantly lesser extent than in controls (*p < 0.05 vs. control)
Fig. 6 Treatment with paraquat and lectin induces impairment of the nigro–vagal pathway. a Representative recordings from the gastric antrum showing that the increase of tone and motility following microinjection of NMDA in the left SNpc was reduced progressively at 2 and 4 weeks after the last gavage treatment. b Bottom panel: graphic summaries showing that 2 or 4 weeks after the paraquat and lectin treatment, microinjection of NMDA in the left SNpc increased gastric antrum tone (n = 9, 6, 10 for control, P + L 2 weeks and P + L 4 weeks, respectively) and motility (n = 7, 7, 9 for control, P + L 2 weeks and P + L 4 weeks, respectively) to a significantly lesser extent than in controls (*p < 0.05 vs. control). c Representative recordings from the gastric antrum showing that the increase of tone and motility following microinjection of TRH (1 pmole/60 nl) in the DMV was reduced progressively at 2 and 4 weeks after the last gavage treatment. d Graphic summaries showing that, 2 or 4 weeks after the paraquat and lectin treatment, microinjection of TRH (0.1–3 pmoles/60 nl) in the DMV increased gastric antrum tone and motility to a significantly lesser extent than in controls (*p < 0.05 vs. control)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 63

Metadata

Authors
Anselmi, L., Bove, C., Coleman, F. H., Le, K., Subramanian, M. P., Venkiteswaran, K., Subramanian, T., & Travagli, R. A.
Affiliations
Pennsylvania State University (US)
Corresponding author
Travagli, R. A.
Venue
npj Parkinson's Disease
Published
2018-09-27
Volume
4
Issue
1
Pages
30-30
ISSN
2373-8057 (ISSN-L)
OpenAlex
W2892234634
Cited by
63
References
62
Citations by year
2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 5 · 2021: 10 · 2020: 9 · 2019: 10
FWCI
4.91
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Parkinson s Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • University of Pennsylvania
  • Pennsylvania State University
  • National Institutes of Health (DIBTH0632)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK055530)
  • National Institute of Neurological Disorders and Stroke (R01NS042402)
  • National Center for Complementary and Integrative Health (R21AT001607)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Parkinson's disease, environmental neurotoxicity, paraquat, lectins, vagus nerve, dorsal motor nucleus of the vagus, substantia nigra pars compacta, dopaminergic neuron loss, gastric dysmotility, L-DOPA, vagotomy, myenteric neurons, rat model

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. https://app.cochat.ai/papers/10.1038/s41531-018-0066-0
The paper
Anselmi, L., Bove, C., Coleman, F. H., Le, K., Subramanian, M. P., Venkiteswaran, K., Subramanian, T., & Travagli, R. A. (2018). Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. npj Parkinson's Disease. https://doi.org/10.1038/s41531-018-0066-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.